Changing role of COX-2 inhibitors in the perioperative period: is parecoxib really the answer?
- PMID: 15845674
- DOI: 10.1213/01.ANE.0000158607.90390.01
Changing role of COX-2 inhibitors in the perioperative period: is parecoxib really the answer?
Comment in
-
Safety of cox-2 selective nonsteroidal antiinflammatory drugs for postsurgical pain.Anesth Analg. 2006 Feb;102(2):645-6; author reply 646. doi: 10.1213/01.ANE.0000190739.71547.39. Anesth Analg. 2006. PMID: 16428581 No abstract available.
Comment on
-
A randomized, double-blind comparison between parecoxib sodium and propacetamol for parenteral postoperative analgesia after inguinal hernia repair in adult patients.Anesth Analg. 2005 May;100(5):1309-1315. doi: 10.1213/01.ANE.0000150972.88708.13. Anesth Analg. 2005. PMID: 15845675 Clinical Trial.
References
-
- Kondro W. Lawsuits mount in wake of rofecoxib (Vioxx) withdrawal. CMAJ 2004;171:1335.
-
- White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg 2002;94:577–85.
-
- Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000;91:1221–5.
-
- Reuben SS, Bhopatkar S, Maciolek H, et al. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002;94:55–9.
-
- Issioui T, Klein KW, White PF, et al. Cost-efficacy of rofecoxib versus acetaminophen for preventing pain after ambulatory surgery. Anesthesiology 2002;97:931–7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
